Skip to main content
DHR
NYSE Life Sciences

丹纳赫(Danaher)提交30亿欧元高级票据发行申请

feedReported by Reuters
Sentiment info
Neutral
Importance info
8
Price
$183.81
Mkt Cap
$130.245B
52W Low
$180.03
52W High
$242.8
Market data snapshot near publication time

summarizeSummary

丹纳赫公司(Danaher Corporation)已提交四部分高级票据发行申请,最高金额为30亿欧元。这一重大融资事件代表着公司债务的重大增加,其发生在公司最近公布强劲的第一季度盈利报告以及建立新50亿美元循环信用额度之后。本次发行将影响丹纳赫的资本结构,并可能用于一般公司目的,包括潜在的收购或重组现有债务。交易者应关注本次发行的最终条款以及资金使用的声明,以获取进一步的影响。

在该公告发布时,DHR的交易价格为$183.81,交易所为NYSE,所属行业为Life Sciences,市值约为$1302.5亿。 52周交易区间为$180.03至$242.80。 这则新闻被评估为中性市场情绪,重要性评分为8/10。 来源:Reuters。


show_chartPrice Chart

Share this article

Copied!

feed DHR - Latest Insights

DHR
Apr 29, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
8
DHR
Apr 23, 2026, 4:15 PM EDT
Filing Type: 424B5
Importance Score:
8
DHR
Apr 22, 2026, 6:03 PM EDT
Source: Reuters
Importance Score:
8
DHR
Apr 22, 2026, 4:34 PM EDT
Filing Type: FWP
Importance Score:
8
DHR
Apr 21, 2026, 6:00 AM EDT
Source: Reuters
Importance Score:
8
DHR
Apr 20, 2026, 5:44 PM EDT
Filing Type: 8-K
Importance Score:
7
DHR
Apr 20, 2026, 5:40 PM EDT
Filing Type: 10-Q
Importance Score:
7
DHR
Apr 17, 2026, 8:33 AM EDT
Source: Wiseek News
Importance Score:
8
DHR
Apr 17, 2026, 8:28 AM EDT
Filing Type: 8-K
Importance Score:
8
DHR
Mar 25, 2026, 8:12 AM EDT
Filing Type: DEFA14A
Importance Score:
7